scholarly article | Q13442814 |
P356 | DOI | 10.1111/LIV.12305 |
P698 | PubMed publication ID | 24034415 |
P50 | author | Ana Catarina Alves | Q39067334 |
Mafalda Bourbon | Q39067353 | ||
P2093 | author name string | Helena Cortez-Pinto | |
Jorge Leitão | |||
Sofia Carvalhana | |||
P2860 | cites work | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management | Q24649618 |
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population | Q33262505 | ||
Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people | Q36334667 | ||
Nonalcoholic fatty liver disease: from steatosis to cirrhosis | Q36382279 | ||
The epidemiology of nonalcoholic fatty liver disease: a global perspective | Q37310275 | ||
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance | Q37552186 | ||
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? | Q45206614 | ||
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. | Q45752530 | ||
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study | Q51541188 | ||
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. | Q51655382 | ||
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | steatosis | Q1365091 |
P304 | page(s) | e111-7 | |
P577 | publication date | 2013-09-04 | |
P1433 | published in | Liver International | Q15765078 |
P1476 | title | How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound | |
P478 | volume | 34 |
Q48303241 | Clinical implications of controlled attenuation parameter in a health check-up cohort. |
Q47581786 | Clinical relevance of liver histopathology and different histological classifications of NASH in adults |
Q54760091 | Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? |
Q40653010 | Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B. |
Q38607766 | Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis |
Q42182031 | Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey |
Q47101292 | Ideal cardiovascular health predicts lower risk of abnormal liver enzymes levels in the Chilean National Health Survey (2009-2010). |
Q60909758 | Liver Fat Content and Body Fat Distribution in Youths with Excess Adiposity |
Q57818077 | Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations |
Q52359166 | Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. |
Q38991269 | Non-invasive diagnosis of hepatic steatosis. |
Q53265078 | Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea. |
Q58727386 | Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study |
Q91552287 | Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance |
Q36658454 | Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease |
Q58549444 | Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease |
Q33885985 | Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study |
Q38954392 | Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis |
Q36195780 | Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article |
Q40606091 | The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis |
Q53382915 | The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP). |
Q36280695 | ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.